Valuation: Acotec Scientific Holdings Limited

Market Cap 1.56B 1.83B 233M 208M 192M 175M 330M 22.12B 335M 2.31B 907M 11.55B 874M 855M 36.8B P/E 2026 *
11.5x
P/E 2027 * 9.19x
Enterprise Value 1.56B 1.83B 233M 208M 192M 175M 330M 22.12B 335M 2.31B 907M 11.55B 874M 855M 36.8B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.71x
Free-Float
16.41%
Yield 2026 *
-
Yield 2027 * -
1 day-0.43%
1 week-2.84%
Current month-7.77%
1 month-3.96%
3 months-29.88%
6 months-50.04%
Current year-56.89%
1 week 5.74
Extreme 5.735
6.05
1 month 5.5
Extreme 5.5
6.32
Current year 5.5
Extreme 5.5
15.32
1 year 5.5
Extreme 5.5
15.32
3 years 5.26
Extreme 5.26
15.47
5 years 4.21
Extreme 4.21
19.88
10 years 4.21
Extreme 4.21
19.88
Manager TitleAgeSince
Chief Executive Officer 54 29/01/2021
Chief Tech/Sci/R&D Officer 48 29/01/2021
Chief Tech/Sci/R&D Officer 85 29/01/2021
Director TitleAgeSince
Chairman 54 29/01/2021
Director/Board Member 56 03/12/2020
Director/Board Member 79 29/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
13/7/26 Other

Chief Executive Officer

-628,316 0.2005%
8/6/23 Other

Chief Executive Officer

7,208,000 2.3000%
24/9/21 Other

Chief Executive Officer

342,000 0.1091%
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-2.84%-54.50%-54.53% 232M
+0.20%+5.31%-17.82%+13.79% 181B
-0.73%+7.09%-0.31%+32.06% 116B
+0.49%+6.25%-20.20%+11.58% 113B
+3.83%+5.50%-44.18%-6.77% 79.83B
-0.14%+5.27%+6.74%+82.45% 65.06B
+2.79%+2.37%+15.93%+68.64% 54.35B
-1.04%+4.35%+3.50%-26.18% 52.23B
+2.41%+8.18%-12.08%+30.45% 44.15B
-1.90%+2.29%+29.72%+8.98% 32.47B
Average +0.55%+4.47%-9.32%+16.05% 73.88B
Weighted average by Cap. +0.60%+5.59%-9.71%+22.11%

Financials

2026 *2027 *
Net sales 728M 856M 109M 97.18M 89.94M 81.94M 154M 10.35B 157M 1.08B 424M 5.41B 409M 400M 17.23B 910M 1.07B 136M 121M 112M 102M 193M 12.94B 196M 1.35B 531M 6.76B 511M 501M 21.53B
Net income 128M 150M 19.17M 17.09M 15.81M 14.41M 27.15M 1.82B 27.61M 190M 74.63M 951M 71.94M 70.41M 3.03B 164M 193M 24.56M 21.89M 20.26M 18.46M 34.79M 2.33B 35.37M 244M 95.62M 1.22B 92.17M 90.21M 3.88B
Net Debt - -
Projected Income Statement - Annual - Acotec Scientific Holdings Limited
Logo Acotec Scientific Holdings Limited
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts its businesses within domestic and overseas markets.
Employees
955
Date Price Change Volume
16/10/26 HK$5.820 -0.43% 614,000
15/10/26 HK$5.845 +1.12% 478,000
14/10/26 HK$5.780 -1.87% 580,000
13/10/26 HK$5.890 +0.17% 565,000
12/10/26 HK$5.880 -1.84% 471,000
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Acotec Scientific Holdings Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.962CNY
Average target price
15.00CNY
Spread / Average Target
+202.22%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Acotec Scientific Holdings Limited
  1. Stock Market
  2. Stocks
  3. 6669 Stock